Yes — most men with a history of prostate cancer can qualify for life insurance, and early-stage, low-grade cases are often among the most favorably underwritten cancer histories in the entire industry. The Gleason score, PSA trend, and time since treatment are what carriers focus on most — though exact waiting periods and outcomes vary by carrier.
Prostate cancer is one of the most common cancer diagnoses in men, and because it’s frequently slow-growing and highly treatable, underwriters have well-developed, often lenient guidelines for evaluating it. Here’s what to expect.
How underwriters evaluate prostate cancer
Prostate cancer underwriting centers on three main factors: the Gleason score (which measures how aggressive the cancer cells appear), the stage at diagnosis, and how your PSA (prostate-specific antigen) has trended since treatment. Time since diagnosis and treatment also matters significantly — the longer your clean follow-up record, the better your outcome.
Because prostate cancer varies so widely in aggressiveness, from cases so slow-growing that doctors recommend active surveillance instead of treatment, to more aggressive forms requiring surgery or radiation, underwriters treat this diagnosis with more nuance than almost any other cancer type.
The table below reflects general industry patterns. Actual outcomes vary meaningfully by carrier and by the specifics of your treatment — some carriers will consider applications as early as 3-12 months post-treatment for favorable cases, while others require longer. Treat this as a starting point for a conversation with your broker.
| Gleason Score / Grade | Typical Waiting Period | Likely Rate Class |
|---|---|---|
| Gleason 6 or below (low-grade) | As early as 3-12 months post-surgery at some carriers; others prefer 1-2 years | Standard to preferred |
| Gleason 7 (intermediate-grade) | Typically 1-5 years disease-free depending on carrier and treatment type | Standard, sometimes with mild rating |
| Gleason 8+ (high-grade) | Often 5+ years disease-free | Table-rated; carrier pool narrows |
These are general patterns — actual outcomes vary by carrier, PSA trend, and treatment type, which is exactly why comparing carriers matters for this diagnosis.
Why PSA monitoring matters so much
After prostate cancer treatment, PSA levels are tracked closely to detect any sign of recurrence. A stable, low, or undetectable PSA over multiple consecutive tests is one of the strongest positive signals you can bring to a life insurance application.
Underwriters typically want to see at least two to three consecutive PSA readings post-treatment showing stability before offering the best available rates. If your PSA has been rising — even slightly — carriers will want a clearer picture from your urologist before making a decision, and some may postpone the application until the trend is better understood.
How treatment type factors in
Prostate cancer treatment varies widely, and underwriters consider the approach as part of the overall picture.
Active surveillance. For very low-risk cases where doctors monitor the cancer rather than treat it immediately, some carriers view this favorably since it reflects a slow-growing, low-aggressiveness diagnosis. Others may want to see eventual treatment or a longer surveillance record before offering top rates — for applicants under 65, some carriers want to see multiple years of a stable PSA on active surveillance before offering coverage.
Surgery (prostatectomy). A common and effective treatment. Clean margins and a stable post-surgical PSA support a favorable underwriting outcome; some carriers will consider applications as early as three months after surgery for favorable cases.
Radiation therapy. Similarly effective, though many carriers require roughly 12 months post-treatment before considering a fully underwritten application, with a stable post-treatment PSA trend supporting standard or better rates over time.
Hormone therapy. Often used for higher-grade or recurrent cases. This is generally viewed as an indicator of more advanced disease and will typically result in a longer required waiting period and closer underwriting review.
What rates actually look like
To illustrate a real baseline: a healthy 63-year-old non-smoker male in Nevada with no cancer history and standard health currently qualifies for roughly $375 to $397 per month for $500,000 of 15-year term coverage across the carriers we checked as of August 2026.
A prostate cancer history typically results in a rated premium above that healthy baseline for a period of time, particularly for higher Gleason scores or more recent treatment. For low-grade, early-stage cases with a stable PSA and enough time since treatment, some carriers will offer standard rates close to the healthy baseline above. For higher-grade cases or those still within the waiting period, a table rating or flat-extra surcharge is common, and the size of that surcharge varies significantly by carrier.
The spread between carriers on prostate cancer cases can be significant, since different companies weigh Gleason score, PSA trend, and treatment type differently. This is where an independent broker makes a measurable difference — matching your specific diagnosis and monitoring history to the carrier most likely to offer the best outcome.
Frequently Asked Questions
Can you get life insurance after prostate cancer?
Yes. Most men with a history of prostate cancer can qualify for life insurance, particularly with a low Gleason score, a stable PSA trend, and time since treatment. Outcomes vary significantly by carrier, so working with a broker who can shop your specific case matters.
What Gleason score is needed to get standard life insurance rates?
Gleason 6 or below is generally viewed most favorably. Some carriers will consider standard to preferred rates within months of successful treatment; others prefer a longer track record. Higher Gleason scores are still insurable but typically require a longer waiting period.
Does PSA level affect my life insurance rate?
Yes. A stable or undetectable PSA over multiple consecutive tests after treatment is one of the strongest positive factors in a prostate cancer application. A rising PSA may result in a postponed decision.
How long after prostate cancer treatment can I apply for life insurance?
This depends on your Gleason score, treatment type, and carrier. Some low-grade cases may be considered within months of treatment, while higher-grade cases typically require several years of stability before standard rates are available.
Is active surveillance for prostate cancer viewed the same as treatment?
Not always. Some carriers view active surveillance favorably since it reflects a low-risk diagnosis, while others prefer to see a longer surveillance record — often several years of stable PSA — or completed treatment before offering top rates.
What helps your application
Get your PSA history organized. Have your urologist provide a summary of your PSA readings since diagnosis and treatment. A clear, stable trend is one of the most persuasive things you can bring to an application.
Document your Gleason score and treatment details. Carriers want specifics — original Gleason score, treatment type, and any pathology report details confirming clean margins if you had surgery.
Stay current with urology follow-up. Consistent monitoring signals to underwriters that any recurrence would be caught early.
Work with a broker who places prostate cancer cases regularly. Carrier guidelines vary enormously on how much weight they give the original diagnosis versus your post-treatment trend. The right match can mean the difference between a heavy rating and standard rates.
If you’re also working out how much coverage you need, our life insurance needs calculator is a good starting point.
Get your free quote today
At Term Insurance Brokers, prostate cancer cases are part of what we handle every week. We’re licensed independent insurance agents representing more than 30 top-rated carriers and know exactly which ones take the most favorable view of your specific Gleason score, treatment history, and PSA trend.
There’s no cost for a quote and no obligation. We do the carrier comparison — you make the decision.
Get Your Free Quote Today
No cost. No obligation. We shop 30+ carriers to find the right fit for you.
| Call 888-972-0024 | Get a Quote |
Term Insurance Brokers is a team of licensed independent insurance agents operating in 35+ states, based in Las Vegas, Nevada. We are not affiliated with any single insurance company. Sample non-cancer-history rate shown reflects current market pricing as of August 2026 for a 63-year-old male applicant in Nevada; actual premiums for any applicant, with or without a cancer history, depend on full underwriting and carrier guidelines at time of application.